Research News From March 14, 2018
advertisement
- A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setting.
- Paracrine Interactions within the Pancreatic Islet Determine the Glycemic Set Point. See also Researchers Confirm Entire Islet Organ is the Master Regulator of Blood Glucose Levels.
- α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes.
- Adrenaline and cortisol levels are lower during nighttime than daytime hypoglycaemia in children with type 1 diabetes.
